159 related articles for article (PubMed ID: 10073783)
21. Quinapril in patients with congestive heart failure: controlled trial versus captopril.
Acanfora D; Furgi G; Trojano L; Picone C; Iannuzzi GL; Rossi M; Papa A; Rengo C; Rengo F
Am J Ther; 1997; 4(5-6):181-8. PubMed ID: 10423609
[TBL] [Abstract][Full Text] [Related]
22. Quinapril therapy in patients with chronic mitral regurgitation.
Schön HR; Schröter G; Barthel P; Schömig A
J Heart Valve Dis; 1994 May; 3(3):303-12. PubMed ID: 8087269
[TBL] [Abstract][Full Text] [Related]
23. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
[TBL] [Abstract][Full Text] [Related]
24. Long-term effects of quinapril with high affinity for tissue angiotensin-converting enzyme after coronary intervention in Japanese.
Otsuka M; Yamamoto H; Okimoto T; Dohi Y; Mito S; Gomyo Y; Fujii T; Matsuura W; Hirai Y; Kohno N
Am Heart J; 2004 Apr; 147(4):662-8. PubMed ID: 15077082
[TBL] [Abstract][Full Text] [Related]
25. Preservation of cardiac function and energy reserve by the angiotensin-converting enzyme inhibitor quinapril during postmyocardial infarction remodeling in the rat.
Hügel S; Horn M; Remkes H; Dienesch C; Neubauer S
J Cardiovasc Magn Reson; 2001; 3(3):215-25. PubMed ID: 11816618
[TBL] [Abstract][Full Text] [Related]
26. Effect of quinapril on in-stent restenosis and relation to plasma apoptosis signaling molecules.
Deftereos S; Giannopoulos G; Kossyvakis C; Kaoukis A; Raisakis K; Driva M; Panagopoulou V; Lappos S; Rentoukas I; Pyrgakis V; Alpert MA
Am J Cardiol; 2010 Jan; 105(1):54-8. PubMed ID: 20102890
[TBL] [Abstract][Full Text] [Related]
27. Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation.
Jondeau G; Dib JC; Dubourg O; Bourdarias JP
Am J Cardiol; 1997 Mar; 79(5):635-8. PubMed ID: 9068523
[TBL] [Abstract][Full Text] [Related]
28. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
Riegger GA
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S41-6. PubMed ID: 1691406
[TBL] [Abstract][Full Text] [Related]
29. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin converting enzyme inhibitors and restenosis: let's stop teasing ourselves.
Mancini GB
Cardiovasc Drugs Ther; 2001 Jul; 15(4):293-5. PubMed ID: 11800410
[No Abstract] [Full Text] [Related]
31. Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure.
Volpe M; Tritto C; DeLuca N; Rubattu S; Mele AF; Lembo G; Enea I; deCampora P; Rendina V; Romano M
Circulation; 1992 Dec; 86(6):1800-9. PubMed ID: 1451252
[TBL] [Abstract][Full Text] [Related]
32. [Angiotensin-converting enzyme, quinapril, in treating chronic cardiac failure].
Gadzhiev AN
Ter Arkh; 2003; 75(1):51-5. PubMed ID: 12652958
[TBL] [Abstract][Full Text] [Related]
33. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
Pelliccia F; Borghi A; Ruggeri A; Cianfrocca C; Morgagni GL; Bugiardini R
Clin Cardiol; 1993 Aug; 16(8):607-12. PubMed ID: 8370193
[TBL] [Abstract][Full Text] [Related]
34. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
Sedman AJ; Posvar E
Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
[TBL] [Abstract][Full Text] [Related]
35. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
Rouleau JL; Warnica WJ; Baillot R; Block PJ; Chocron S; Johnstone D; Myers MG; Calciu CD; Dalle-Ave S; Martineau P; Mormont C; van Gilst WH;
Circulation; 2008 Jan; 117(1):24-31. PubMed ID: 18071079
[TBL] [Abstract][Full Text] [Related]
36. Heart failure development in rats with ascending aortic constriction and angiotensin-converting enzyme inhibition.
Turcani M; Rupp H
Br J Pharmacol; 2000 Aug; 130(7):1671-7. PubMed ID: 10928973
[TBL] [Abstract][Full Text] [Related]
37. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
[TBL] [Abstract][Full Text] [Related]
38. Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy.
Kontopoulos AG; Athyros VG; Didangelos TP; Papageorgiou AA; Avramidis MJ; Mayroudi MC; Karamitsos DT
Diabetes Care; 1997 Mar; 20(3):355-61. PubMed ID: 9051387
[TBL] [Abstract][Full Text] [Related]
39. Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: randomised, placebo controlled trial.
Lough M; Cleland J; Langan J; Cowley A; Wade A
BMJ; 1998 Nov; 317(7169):1352-3. PubMed ID: 9812933
[No Abstract] [Full Text] [Related]
40. Beneficial effect of quinapril in patients with angiotensin-converting enzyme D allele after coronary stenting.
Okumura K; Kamiya H; Matsui H; Sone T; Kondo J; Tsuboi H; Mukawa H
Atherosclerosis; 2001 Dec; 159(2):527-8. PubMed ID: 11730835
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
